Thanks Wold, it's a pleasant change to have a civil discussion.
"Failure is a part of biotech testing anyone who invests in a biotech and isn't aware of that fact is investing blindly." Totally agree, and this is the essence of my posts on the subject.
The reason I raise the question is because I don't believe that the information coming out of the company is either sufficiently complete, or, a true indication of how far it has advanced. That is my opinion, based on what I know, or believe, and others can agree, disagree, dispute, or ignore, as they see fit.
But rather than pursue me for details that I'm not in a position to discuss, why don't those that have a genuine interest in this matter (rather than slagging me off for having the audacity to raise it) ask Graham the question (in writing) - "Have any of the Recce products ever received adverse findings from any of your trials, or, from other institutions or individuals?"
Hopefully, his answer will satisfy everybody's curiosity.
RCE Price at posting:
$1.12 Sentiment: Sell Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)